COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,804 Articles (22,527 medRxiv, 8,277 bioRxiv)

Most recent first Previous |  Page 2441: Articles 24401-24410  | Next

Empirical non-linear modeling & forecast of global daily deaths of COVID-19 pandemic & evidence that a third wave is beginning to decay
Sanchez-Sesma, J.
10.1101/2020.07.07.20147900 — Posted: 2020-07-13
Flexibility and mobility of SARS-CoV-2-related protein structures
Rudolf A Roemer, Navodya Sophie Roemer, Anne Katrine Wallis
10.1101/2020.07.12.199364 — Posted: 2020-07-12
Tafenoquine inhibits replication of SARS-Cov-2 at pharmacologically relevant concentrations in vitro
Geoffrey Dow, Angela Luttick, Jen Fenner, David Wesche, Karen Rowland Yeo, Craid Rayner
10.1101/2020.07.12.199059 — Posted: 2020-07-12
ACE2-expressing endothelial cells in aging mouse brain
SU Bin Lim, Valina L. Dawson, Ted M. Dawson, Sung-Ung Kang
10.1101/2020.07.11.198770 — Posted: 2020-07-11
A Highly Immunogenic Measles Virus-based Th1-biased COVID-19 Vaccine
Cindy Hoerner, Christoph Schuermann, Arne Auste, Aileen Ebenig, Samada Muraleedharan, Maike Herrmann, Barbara Schnierle, Michael D Muehlebach
10.1101/2020.07.11.198291 — Posted: 2020-07-11
A simple protein-based SARS-CoV-2 surrogate neutralization assay
Kento T Abe, Zhijie Li, Reuben Samson, Payman Samavarchi-Tehrani, Emelissa J Valcourt, Heidi Wood, Patrick Budylowski, Alan Dupuis, Roxie C Girardin, Bhavisha Rathod, Karen Colwill, Allison McGeer, Samira Mubareka, Jennifer L. Gommerman, Yves Durocher, Mario A Ostrowski, Kathleen McDonough, Michael A. Drebot, Steven J. Drews, James M Rini, Anne-Claude Gingras
10.1101/2020.07.10.197913 — Posted: 2020-07-11
Identifying SARS-CoV-2 entry inhibitors through drug repurposing screens of SARS- S and MERS-S pseudotyped particles
Catherine Z. Chen, Miao Xu, Manisha Pradhan, Kirill Gorshkov, Jennifer Petersen, Marco R. Straus, Wei Zhu, Paul Shinn, Hui Guo, Min Shen, Carleen Klumpp-Thomas, Samuel G. Michael, Joshua Zimmerberg, Wei Zheng, Gary R Whittaker
10.1101/2020.07.10.197988 — Posted: 2020-07-11
No Excess Mortality of COVID-19 in Japan until April, 2020
Kurita, J., Sugawara, T., Sugishita, Y., Ohkusa, Y.
10.1101/2020.07.09.20143164 — Posted: 2020-07-11
SARS-CoV-2 RNA extraction using magnetic beads for rapid large-scale testing by RT-qPCR and RT-LAMP
Klein, S., Mueller, T. G., Khalid, D., Sonntag-Buck, V., Heuser, A.-M., Glass, B., Meurer, M., Morales, I., Schillak, A., Freistaedter, A., Ambiel, I., Winter, S. L., Zimmermann, L., Naumoska, T., Bubeck, F., Kirrmaier, D., Ullrich, S., Barreto-Miranda, I., Anders, S., Grimm, D., Schnitzler, P., Knop, M., Kraeusslich, H.-G., Dao Thi, V. L., Boerner, K., Chlanda, P.
10.1101/2020.07.08.20147561 — Posted: 2020-07-11
COVID-19 causing HELLP-like syndrome in pregnancy and role of angiogenic factors for differential diagnosis
Figueras, F., LLurba, E., Martinez-Portilla, R., Mora, J., Crispi, F., Gratacos, E.
10.1101/2020.07.10.20133801 — Posted: 2020-07-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).